Cargando…
Induction of autophagy-dependent ferroptosis to eliminate drug-tolerant human retinoblastoma cells
Carboplatin is the most used first-line drug for the treatment of human retinoblastoma (RB), a rare form of cancer in infancy and childhood. However, the clinical application of carboplatin is restricted due to the emergence of acquired multi-drug resistance (MDR) after long-term treatment. Here, we...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9163041/ https://www.ncbi.nlm.nih.gov/pubmed/35654783 http://dx.doi.org/10.1038/s41419-022-04974-8 |